Embracing Cultural Humility in End-of-Life Care
Note: Institutional group rates are available upon request
Select type to purchase:
Funding Disclosure: No commercial funding has been accepted for the activity.
Christine Kucinskis, LCSW, CSW-G, ACHP-SW
Social Work Manager
MJHS Hospice and Palliative Care
Purpose: The purpose of this webinar is to acquire the knowledge and skills to identify and address cultural diversity in hospice and palliative care and incorporate best practices in assessment and intervention.
- Review the theory on the role of culture in end-of-life care
- Identify best practices in culturally competent assessment
- Illustrate best practices through a case narrative
- Practice death awareness activities
- Identify best practices in culturally competent intervention
Why Do I Need to Know This?
Culture is recognized as an important domain in hospice and palliative care. Health disparities and culture can present barriers to informed decision-making and treatment in end-of-life care and working with different cultural groups falls to every member of the health care team. Social workers are trained in advocacy, cross-cultural communication, and patient-centered care, making this topic essential to their practice.
Target Audience: Social workers and healthcare coaches
Criteria for Successful Completion:
- Attendance at entire session
- Submission of completed evaluation form
- Successful completion of a posttest (80% passing grade)
Continuing Education Credits: 1.0
Release Date: April 5, 2018
Expiration Date: January 31, 2022
Continuing Education Accreditation:
Social Workers: MJHS Institute for Innovation in Palliative Care is recognized by the New York State Education Department’s State Board for Social Work as an approved provider of continuing education for licensed social workers #SW-0242.
Individual: $25 (includes CE certificate)
Christine Kucinskis, LCSW, CSW-G, ACHP-SW, has no financial arrangements or affiliations with any commercial entities whose products, research or services may be discussed in these materials. Any discussion of investigational or unlabeled uses of a product will be identified.
Russell K. Portenoy, MD, Faculty and Planner, has indicated a relationship with Tabula Rasa for research support.
No other Planning Committee Member has any disclosures.
Planning Committee Members
Lara Dhingra, PhD
Colleen Fleming-Damon, PhDc, ANP-BC, ACHPN, FT
Myra Glajchen, DSW
Helena Knotkova, PhD
Russell K. Portenoy, MD
Karen Richards, PhD, EdS
Wini Schein, BA